# Ternium S.A.: financial statements, quarterly

TX · NYSE · CIK 1342874 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tx.md) · [Financials](/companies/tx/financials.md) · [Filings](/companies/tx/filings.md) · [Insiders](/companies/tx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001342874-18-000009.md) | [0.2](/filings/0001342874-19-000026.md) | [0.2](/filings/0001342874-20-000029.md) | [0.3](/filings/0001342874-21-000031.md) | [0.3](/filings/0001342874-22-000023.md) | [0.5](/filings/0001342874-23-000021.md) | [0.5](/filings/0001342874-24-000018.md) | [1.3](/filings/0001342874-25-000024.md) | [1.7](/filings/0001342874-26-000020.md) | [1.8](/filings/0001342874-26-000020.md) | [1.7](/filings/0001342874-26-000020.md) | [1.5](/filings/0001342874-26-000020.md) |
| Current assets | $bn | not reported | not reported | [2.7](/filings/0001342874-18-000009.md) | [4.4](/filings/0001342874-19-000026.md) | [4.4](/filings/0001342874-20-000029.md) | [4.2](/filings/0001342874-21-000031.md) | [4.6](/filings/0001342874-22-000023.md) | [8.6](/filings/0001342874-23-000021.md) | [8.8](/filings/0001342874-24-000018.md) | [12.0](/filings/0001342874-25-000024.md) | [11.1](/filings/0001342874-26-000020.md) | [9.8](/filings/0001342874-26-000020.md) |
| Total assets | $bn | not reported | not reported | [8.3](/filings/0001342874-18-000009.md) | [12.1](/filings/0001342874-19-000026.md) | [12.5](/filings/0001342874-20-000029.md) | [12.9](/filings/0001342874-21-000031.md) | [12.9](/filings/0001342874-22-000023.md) | [17.1](/filings/0001342874-23-000021.md) | [17.5](/filings/0001342874-24-000018.md) | [24.2](/filings/0001342874-25-000024.md) | [23.1](/filings/0001342874-26-000020.md) | [23.6](/filings/0001342874-26-000020.md) |
| Current liabilities | $bn | not reported | not reported | [1.8](/filings/0001342874-18-000009.md) | [2.8](/filings/0001342874-19-000026.md) | [1.8](/filings/0001342874-20-000029.md) | [1.8](/filings/0001342874-21-000031.md) | [1.9](/filings/0001342874-22-000023.md) | [3.2](/filings/0001342874-23-000021.md) | [2.2](/filings/0001342874-24-000018.md) | [3.8](/filings/0001342874-25-000024.md) | [3.8](/filings/0001342874-26-000020.md) | [3.9](/filings/0001342874-26-000020.md) |
| Total liabilities | $bn | not reported | not reported | [3.2](/filings/0001342874-18-000009.md) | [6.3](/filings/0001342874-19-000026.md) | [5.1](/filings/0001342874-20-000029.md) | [5.2](/filings/0001342874-21-000031.md) | [4.4](/filings/0001342874-22-000023.md) | [4.9](/filings/0001342874-23-000021.md) | [3.7](/filings/0001342874-24-000018.md) | [7.4](/filings/0001342874-25-000024.md) | [7.0](/filings/0001342874-26-000020.md) | [7.5](/filings/0001342874-26-000020.md) |
| Shareholders' equity | $bn | [5.6](/filings/0001342874-18-000009.md) | [4.8](/filings/0001342874-19-000026.md) | [4.4](/filings/0001342874-18-000009.md) | [5.0](/filings/0001342874-19-000026.md) | [6.4](/filings/0001342874-20-000029.md) | [6.6](/filings/0001342874-21-000031.md) | [7.3](/filings/0001342874-22-000023.md) | [10.5](/filings/0001342874-23-000021.md) | [11.8](/filings/0001342874-24-000018.md) | [12.4](/filings/0001342874-25-000024.md) | [12.0](/filings/0001342874-26-000020.md) | [11.9](/filings/0001342874-26-000020.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 2,004,743,442 at 2025-12-31, from the cover of the [20-F filed 2026-03-31](/filings/0001342874-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.